Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ELI LILLY AND COMPANY

(LLY)
  Report
Delayed Nyse  -  04:03 2022-09-29 pm EDT
330.01 USD   -1.31%
10:24aOncology Institute Enrolls First Two Patients in US in Late-Stage Cancer Treatment Trial
MT
09/28Biogen shares soar on landmark Alzheimer's data
RE
09/28Eli Lilly Up Over 7%, on Track for Record High Close -- Data Talk
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday

08/04/2022 | 09:17am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BECTON, DICKINSON AND COMPANY -1.84% 226.12 Delayed Quote.-7.99%
CIGNA CORPORATION -0.70% 280.56 Delayed Quote.22.18%
ELI LILLY AND COMPANY -1.31% 330.01 Delayed Quote.21.06%
NASDAQ COMPOSITE -2.84% 10737.51 Real-time Quote.-29.36%
All news about ELI LILLY AND COMPANY
10:24aOncology Institute Enrolls First Two Patients in US in Late-Stage Cancer Treatment Tria..
MT
09/28Biogen shares soar on landmark Alzheimer's data
RE
09/28Eli Lilly Up Over 7%, on Track for Record High Close -- Data Talk
DJ
09/28MarketScreener's World Press Review : September 28, ..
MS
09/28Thermo Fisher Scientific's Cancer Screening Technology Gets FDA Approval
MT
09/27Eisai says Alzheimer's drug succeeds in slowing cognitive decline
RE
09/27Eli Lilly Faces US Lawsuit Over Age Discrimination In Sales Jobs
MT
09/26Eli Lilly sued for age discrimination by U.S. agency EEOC
RE
09/23Medical device makers see little impact from Fiona on Puerto Rico operations
RE
09/22US Stocks End Lower Thursday Despite Healthcare Gains
MT
More news
Analyst Recommendations on ELI LILLY AND COMPANY
More recommendations
Financials (USD)
Sales 2022 28 822 M - -
Net income 2022 6 377 M - -
Net Debt 2022 10 150 M - -
P/E ratio 2022 47,9x
Yield 2022 1,16%
Capitalization 314 B 314 B -
EV / Sales 2022 11,2x
EV / Sales 2023 10,6x
Nbr of Employees 35 000
Free-Float 99,7%
Chart ELI LILLY AND COMPANY
Duration : Period :
Eli Lilly and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ELI LILLY AND COMPANY
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 330,01 $
Average target price 337,76 $
Spread / Average Target 2,35%
EPS Revisions
Managers and Directors
David A. Ricks Chairman, President & Chief Executive Officer
Anat Ashkenazi Chief Financial Officer & Senior Vice President
Daniel M. Skovronsky Chief Scientific Officer & Senior Vice President
Diogo Rau Senior VP, Chief Information & Digital Officer
Alonzo Weems Senior VP, Chief Ethics & Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
ELI LILLY AND COMPANY21.06%317 719
JOHNSON & JOHNSON-3.82%437 390
ROCHE HOLDING AG-14.15%273 173
ABBVIE INC.6.79%255 667
PFIZER, INC.-25.22%249 357
NOVO NORDISK A/S3.96%224 155